Live
- Army's swift action prevented Kolkata fire from spreading: Defence Ministry
- State Police tried to murder Ravi- Union minister
- FDI flow into India from Gulf countries surges to $24.54 bn in 12 years
- BBL: McSweeney hits fiery 78 to guide Heat to thrilling win after Australia snub
- 'Exceptional case..': Delhi HC orders revision of CLAT-2025 results
- South Korea reports new avian influenza case at regional farm
- US egg prices soar to yearly high amid bird flu, holiday demand
- Ayushman Bharat proving to be boon for people in Gujarat's Kheda
- SEBI takes strict action in front running case, bars 9 entities, seizes over Rs 21 crore (Lead)
- Grand 30th Alumni Reunion at Vattam Jawahar Navodaya Vidyalaya
Sun Pharma to buyout local partner in Mexican arm
Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million (over Rs 75 crore).
New Delhi: Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million (over Rs 75 crore).
The company has signed a binding letter of intent to acquire the balance 25 percent outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75 percent shares, Sun Pharmaceutical Industries said in a regulatory filing. The balance of 25 percent is held by local partner Indi Pharma S.A.P.I. de CV, it added. The cost of acquisition is MXN 161.85 million, it added.
"The acquisition enables Sun Pharma to acquire the balance 25 percent stake held by the local partner," the company said, adding it would be done through a wholly-owned subsidiary Sun Pharma (Netherlands) B.V. The acquisition is likely to be completed by October 31, 2023, and after that, Sun Pharma de Mexico SA de CV will become a wholly-owned subsidiary of the company, it said. Sun Pharma de Mexico is engaged in the marketing and distribution of pharmaceutical products in Mexico.
